Dr. Robert Lee Hong, MD

Dr. Hong practices at VHC Health in Arlington, Virginia, part of VHC Health.

Dr. Hong's NPI, 1952572604, was assigned on March 20, 2008. Dr. Hong graduated from Medical College of Georgia in 2003. Dr. Hong holds Virginia license 0101242910.

Dr. Hong's primary practice is VHC Health, at 1701 North George Mason Drive, Arlington, VA 22205 in Arlington County. The practice phone is (703) 558-5000.

Dr. Hong's primary practice is VHC Health in Arlington, Virginia, part of VHC Health. Dr. Hong is also affiliated with Inova Fairfax Hospital. The medical group on file is Arlington Radiation Oncology. Dmand AI also links Dr. Hong to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hong practices, 4 sites in all. Vendor and product names are available with a free account.

Therapeutic radiology is Dr. Hong's primary specialty in the NPI Registry, under taxonomy code 2085R0203X. Dr. Hong is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Hong's licenses on file in 3 states: Virginia, Maryland and Illinois.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Hong treats.

CMS data shows 2,453 Medicare services from Dr. Hong across 21 procedure codes in 2024, for 288 Medicare patients. Medicare paid $168,620 for them.

CMS counts 288 Medicare patients who saw Dr. Hong in 2024. The largest group is 75 to 84, with 142 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hong's median patient age at 72, with 50% women.

In 2024, Dr. Hong wrote 50 Medicare Part D claims for 28 patients. 88% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $470 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 55 out of 100 for Dr. Hong for performance year 2024, reported individually. Dr. Hong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hong as offering telehealth.

Dmand AI links 9 papers to Dr. Hong, published from 2001 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Tumor Burden and Radiosurgery. Dr. Hong has published most often in Int J Radiat Oncol Biol Phys. Dr. Hong's most frequent co-authors are Nadim M. Nasr, MD, Anthony J. Caputy, MD and David R. Duhamel, MD.

CMS Open Payments shows 48 general payments to Dr. Hong from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Viewray Technologies Inc paid the most, $319. It also lists 1 research payment totaling $1,350 in 2016.

Dmand AI lists 1 award for Dr. Hong, most recently Lunsford Leksell Radiosurgery Award in 2022.

Dr. Hong graduated from Medical College of Georgia in 2003. Dr. Hong is a member of ASTRO.

Dr. Hong is in network with 16 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.